Christopher Gallen

Company: Treos Bio Inc.

Job title: bottom Dog

Seminars:

Chairman’s Opening Remarks 9:15 am

Read more

day: Day Two

Industry Leader’s Fireside Chat 11:00 am

An executive panel discussion from the C-level leaders of the field to set the scene on neoantigen based therapy development.Read more

day: Day Two

Treos’ Novel & Potentially Transformative Big Data Approach to Increasing the Effectiveness of Cancer Vaccines by Incorporating a Systematic Understanding of Antigen Targets & HLA Responses 10:00 am

Treos’ approach to producing two families of off-the-shelf personalized cancer vaccines Clinical data supporting the utility of the Treos approach A systematic approach to creating the future of cancer vaccinesRead more

day: Day Two

Chair’s Opening Remarks 8:15 am

Read more

day: Day One